Invasive Pulmonary Aspergillosis Clinical Trial
The purpose of this study is to evaluate the diagnostic potential of biomarkers for invasive pulmonary aspergillosis in exhaled breath condensate.
Invasive pulmonary aspergillosis (IPA) is a life-threatening infection in immunocompromised patients. The poor prognosis of the disease is partly attributed to difficulties encountered with the diagnosis of this infection. Invasive sampling procedures are often precluded in these patients. In addition, conventional diagnostic techniques lack sensitivity. Recently there has been increasing interest in the investigation of the lungs by noninvasive means including measurement of biomarkers in exhaled breath (e.g. NO) and those found in the cooled and condensed exhalate,termed EBC. It has been demonstrated that a measurable fraction of the EBC in healthy subjects is derived from aerosolized airway lining fluid. The presence of biomarkers for IPA will be investigated in EBC of patients with IPA, compared to controls. ;
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01782131 -
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
|
Phase 3 | |
| Recruiting |
NCT05138666 -
Non-invasive Tools to Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Conditions.
|
N/A | |
| Not yet recruiting |
NCT02234739 -
Voriconazole for IPA in Chinese Patients With COPD
|
Phase 4 | |
| Completed |
NCT01615809 -
Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia
|
Phase 2 | |
| Completed |
NCT04267497 -
Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study)
|
Phase 1 | |
| Recruiting |
NCT05860387 -
Early Diagnosis of Invasive Lung Aspergillosis
|
||
| Withdrawn |
NCT01188759 -
Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects
|
Phase 3 | |
| Completed |
NCT00923832 -
Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis
|
N/A | |
| Recruiting |
NCT05982912 -
VOC in Breath Samples for the Diagnosis of IPA
|
||
| Not yet recruiting |
NCT02100761 -
CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients
|
N/A | |
| Recruiting |
NCT00986713 -
Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation
|
Phase 4 | |
| Recruiting |
NCT05569824 -
LFD of Aspergillus Antigen in Paediatrics
|
||
| Not yet recruiting |
NCT04848831 -
Diagnosis of Invasive Pulmonary Aspergillosis, Specific Testing in Bronchial Secretions Versus Bronchoalveolar Fluid
|
||
| Completed |
NCT04077697 -
Clinical and Prognostic Comparisons Between Invasive Pulmonary Aspergillosis With or Without Invasive Tracheobronchitis During Severe Influenza: a Retrospective Multicenter Cohort Study.
|
||
| Completed |
NCT03672292 -
Study to Evaluate the Safety and Efficacy of the Coadministration of Ibrexafungerp (SCY-078) With Voriconazole in Patients With Invasive Pulmonary Aspergillosis
|
Phase 2 | |
| Recruiting |
NCT01499433 -
Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease
|
Phase 4 | |
| Completed |
NCT00501098 -
Prophylaxis of Fungal Invasive Infections in Leukemia
|
Phase 2 | |
| Recruiting |
NCT03748069 -
Influenza Associated Aspergillosis In-depth Investigation
|
||
| Completed |
NCT02058316 -
Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter Study
|
||
| Terminated |
NCT03327727 -
VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults
|
Phase 2 |